PCRX
What one share of Pacira Biosciences holds
Pharmaceutical Preparations
We were incorporated in Delaware under the name Blue Acquisition Corp. in December 2006 and changed our name to Pacira, Inc. in June 2007. In October 2010, we changed our name to Pacira Pharmaceuticals, Inc. and in April 2019, we changed our name to Pacira BioSciences, Inc.
Pacira Biosciences’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $17.93 |
|---|---|
| Profit | $0.35 |
| Capex (buildings and equipment) | $0.20 |
| Free cash flow | $4.31 |
| Cash and investments | $5.17 |
| Debt | $9.12 |
| Book value | $16.87 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $7.42 | −$1.02 | $0.66 | $0.23 | — | $5.84 |
| 2017 | $7.20 | −$1.07 | $0.48 | −$0.04 | — | $6.87 |
| 2018 | $8.24 | −$0.01 | $0.35 | $0.84 | — | $7.79 |
| 2019 | $10.14 | −$0.27 | $0.24 | $1.45 | — | $8.47 |
| 2020 | $9.84 | $3.33 | $0.87 | $0.90 | — | $14.20 |
| 2021 | $11.87 | $0.92 | $1.01 | $1.75 | — | $16.33 |
| 2022 | $14.33 | $0.34 | $0.65 | $2.48 | — | $16.87 |
| 2023 | $12.99 | $0.91 | $0.29 | $2.68 | — | $18.72 |
| 2024 | $15.16 | −$2.15 | $0.23 | $3.87 | — | $16.83 |
| 2025 | $16.13 | $0.16 | $0.34 | $3.03 | — | $16.86 |